Pricing Log in Create free account
Friday 6 November 2026 Export VCEL’s income statement to Excel — free account

Vericel Corporation

VCEL Healthcare Biotechnology

Vericel Corporation’s revenue for fiscal 2025 (year ended December 2025) was $276.3 million, up 16.5% from fiscal 2024.

Revenue
+26.5%
EPS
+180.0%
Free cash flow
−19.4%

Quarter to September 2026, against a year earlier

53.64 1.86 +3.59%
Market cap
$2.7B
P/E
77.8×
Fwd P/E
72.9×
Dividend yield
—
F-score
7/9
Altman Z
8.21
Beneish M
−2.53
Dividend safety
n/a
Overview
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios

Vericel Corporation (VCEL) EV/EBITDA

Alert me on EV/EBITDA

As of 5 November 2026, Vericel Corporation (VCEL) trades at a EV/EBITDA of 79.1×. Over the past ten years it has ranged from 0.0× (March 2024) to 3,596× (April 2024); the current reading is higher than 76% of that period. That is above the Biotechnology industry median of 0.7× and above the Healthcare sector median of 8.4×.

EV/EBITDA, daily

Embed this chart

Annual newest first

Period EV/EBITDA Change
FY2025 74.8× (72.14%)
FY2024 269× —
FY2023 0.0× —
FY2022 0.0× —
FY2021 0.0× —
FY2020 264× —
FY2019 0.0× —
FY2018 0.0× —
FY2017 0.0× —
FY2016 0.0× —

Quarterly newest first

Period EV/EBITDA Change
Sep 2026 60.8× (10.60%)
Jun 2026 68.0× 26.59%
Mar 2026 53.7× (28.20%)
Dec 2025 74.8× (14.03%)
43 more quarters

Against its own ten years

Low 0.0× High 3,596×
Ten-year median 0.0×
Current reading's percentile 76

EV/EBITDA against peers

Company EV/EBITDA
PVLA Palvella Therapeutics, Inc. compare n/m
PHVS Pharvaris N.V. compare n/m
BHVN Biohaven Ltd. compare n/m
VERA Vera Therapeutics, Inc. compare n/m
CLDX Celldex Therapeutics, Inc. compare n/m
IMNM Immunome, Inc. compare n/m
AUPH Aurinia Pharmaceuticals Inc compare 10.5×
ADMA ADMA Biologics Inc compare 13.0×
VCEL Vericel Corporation 79.1×
Biotechnology industry median 0.7×
Healthcare sector median 8.4×
Market median 10.9×

What EV/EBITDA is

Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)

The full definition of EV/EBITDA →

More on VCEL